Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
08 Nov 2023 |
On P&L |
The Company releases the press release related to the first nine months of 2023 financial results
|
Download |
|
08 Nov 2023 |
On P&L |
The Company releases the first nine months 2023 financial results presentation
|
Download |
|
26 Jul 2023 |
On P&L |
The Company releases the press release related to the first half 2023 financial results
|
Download |
|
26 Jul 2023 |
On P&L |
The Company releases the first half 2023 financial results presentation
|
Download |
|
26 Jul 2023 |
On buy-back programmes |
The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
24 Feb 2021 |
Annual Report regarding remuneration of the members of the Board of Directors |
ROVI releases the 2020 annual report regarding remuneration of the members of the Board of Directors
|
Download |
|
24 Feb 2021 |
On business and financial situation |
The company releases the press release related to 2020 financial results
|
Download |
|
24 Feb 2021 |
On business and financial situation |
ROVI releases the 2020 Results presentation
|
Download |
|
24 Feb 2021 |
Annual Corporate Governance Report |
ROVI releases the 2020 Annual Corporate Governance Report
|
Download |
|
11 Jan 2021 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the fourth quarter of 2020
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
06 Apr 2017 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted in the first quarter of 2017
|
Download |
|
13 Mar 2017 |
Otros sobre negocio y situación financiera |
The Company releases the presentation related to its biosimilar of Enoxaparin
|
Download |
|
07 Mar 2017 |
Otros sobre negocio y situación financiera |
ROVI informs that the Decentralised procedure used for the registration of its biosimilar of enoxaparin has been completed with positive outcome
|
Download |
|
16 Feb 2017 |
Otros sobre Gobierno Corporativo |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
|
16 Feb 2017 |
Informe anual de remuneraciones de los consejeros |
ROVI releases the 2016 annual report regarding remuneration of the members of the Board of Directors
|
Download |
Pages
